GlassScriptPhysician profile
Animesh S Bhatia
NPI 1801803762
$45,616.84
in general payments reported to CMS, 2019-2025
23 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $2,800 · 2021: $11K · 2022: $6,172 · 2023: $685 · 2024: $328 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,186.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $20,066.92 | 2019-2022 | |
| Smith+Nephew, INC. | $14,245.75 | 2019-2024 | Grafix Pl |
| Kci USA, INC. | $3,400.00 | 2019 | |
| Kerecis Limited | $1,848.49 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Osiris Therapeutics INC. | $1,842.30 | 2019 | |
| Urgo Medical North America, LLC | $1,837.50 | 2020 | |
| Flower Orthopedics Coporation | $1,050.00 | 2019 | |
| Nevro Corp. | $186.43 | 2022-2024 | Senza |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Paratek Pharmaceuticals, INC. | $132.20 | 2023-2024 | Nuzyra |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $124.90 | 2023 | Auvelity |
| Organogenesis INC. | $124.84 | 2022 | |
| Lilly USA, LLC | $121.85 | 2025 | Zepbound |
| Angiodynamics, INC. | $114.98 | 2023 | Auryon Laser System 100-120 Vac |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $41.25 | 2024 | Activ.A.C. |
| Wound Management Technologies, INC | $40.11 | 2019 | |
| Access Pro Medical, LLC | $39.00 | 2025 | Matriderm |
| Melinta Therapeutics, LLC | $37.31 | 2019 | |
| Horizon Therapeutics Plc | $27.82 | 2020-2021 | |
| Integra Lifesciences Corporation | $16.78 | 2019 | |
| Orthofix Medical, INC. | $13.48 | 2025 | Physio-Stim |
| Grt US Holding, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Animesh Bhatia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.